Terug
Dagbereik
€ 34,81
€ 35,91
52-Weeksbereik
€ 21,97
€ 48,25
Volume
259.798
50D / 200D Gem.
€ 39,51
/
€ 39,76
Vorige Slotkoers
€ 35,72
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 175,0 | 0,3 |
| P/B | 3,8 | 2,9 |
| ROE % | 2,7 | 3,7 |
| Net Margin % | 2,2 | 3,8 |
| Rev Growth 5Y % | 10,2 | 10,0 |
| D/E | 0,7 | 0,2 |
Koersdoel Analisten
Hold
€ 52,00
+45.7%
Low: € 50,00
High: € 55,00
Forward K/W
100,0
Forward WPA
€ 0,36
WPA Groei (sch.)
+0,0%
Omzet Sch.
490 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,72
€ 1,69 – € 1,73
|
790 M | 1 |
| FY2029 |
€ 1,33
€ 1,31 – € 1,34
|
700 M | 1 |
| FY2028 |
€ 0,87
€ 0,76 – € 0,97
|
620 M | 2 |
Belangrijkste Punten
Revenue grew 10,24% annually over 5 years — strong growth
ROE of 2,70% is below average
Negative free cash flow of -911.000,0
P/E of 175,01 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,35%
Capital efficient — spends only 8,85% of revenue on capex
Groei
Revenue Growth (5Y)
10,24%
Revenue (1Y)13,59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
2,70%
ROIC2,71%
Net Margin2,21%
Op. Margin6,06%
Veiligheid
Debt / Equity
0,65
Current Ratio2,99
Interest Coverage1,01
Waardering
P/E Ratio
175,01
P/B Ratio3,81
EV/EBITDA72,41
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,59% | Revenue Growth (3Y) | 11,65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10,24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 441,33M | Net Income (TTM) | 9,77M |
| ROE | 2,70% | ROA | 1,10% |
| Gross Margin | 61,28% | Operating Margin | 6,06% |
| Net Margin | 2,21% | Free Cash Flow (TTM) | -911.000,0 |
| ROIC | 2,71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,65 | Current Ratio | 2,99 |
| Interest Coverage | 1,01 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 175,01 | P/B Ratio | 3,81 |
| P/S Ratio | 3,87 | PEG Ratio | -1,25 |
| EV/EBITDA | 72,41 | Dividend Yield | 0,00% |
| Market Cap | 1,71B | Enterprise Value | 1,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 441,33M | 388,54M | 354,00M | 313,79M | 298,84M |
| Net Income | 9,77M | -13,36M | -30,69M | -19,19M | -14,83M |
| EPS (Diluted) | 0,21 | -0,32 | -0,75 | -0,48 | -0,38 |
| Gross Profit | 270,45M | 248,78M | 229,18M | 202,52M | 197,51M |
| Operating Income | 26,75M | 38,87M | 5,74M | 6,20M | 8,12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 884,80M | 789,10M | 792,40M | 762,80M | 793,05M |
| Total Liabilities | 436,56M | 512,90M | 510,62M | 478,47M | 492,32M |
| Shareholders' Equity | 448,23M | 276,20M | 281,78M | 284,33M | 300,73M |
| Total Debt | 292,04M | 362,26M | 358,34M | 356,83M | 362,04M |
| Cash & Equivalents | 64,91M | 53,46M | 58,94M | 39,35M | 55,01M |
| Current Assets | 303,55M | 290,08M | 280,67M | 247,33M | 247,70M |
| Current Liabilities | 101,56M | 66,82M | 57,86M | 49,68M | 44,95M |